Published: 08-11-2024 12:34 | Updated: 14-11-2024 14:02

Swedish Cancer Society grants nearly SEK 30 million to MedH researchers

Photo of woman blowing confetti.
Photo: iStock

We congratulate the eight researchers at the Department of Medicine, Huddinge who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2029. Together, the MedH researchers are awarded grants of nearly SEK 30 million.

Karl Ekwall, Biosciences and Nutrition Unit.
Title: Chromatin remodeling and histone modifications in cellular quiescence.
Amount granted for 2025-2026: SEK 3 000 000.

Petter Höglund, Hematology Unit/HERM.
Title: Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental
studies.
Amount granted for 2025-2027: SEK 3 750 000.

Martin Jädersten, Hematology Unit/HERM.
Title: Targeting SAMHD1 in relapsed/refractory AML: The FLAsH-IV trial.
Amount granted for 2025-2029: SEK 5 000 000.

Isabelle Magalhaes, Hematology Unit/HERM.
Title: Identification of cytotoxic, resilient MSLN CAR T cells for solid tumors treatment.
Amount granted for 2025-2027: SEK 3 000 000.

Karl-Johan Malmberg, Center for Infectious Medicine (CIM).
Title: Off-the-shelf Adaptive NK Cell Therapy Guided by Protein Biologics and Precision Engineering.
Amount granted for 2025-2027: SEK 5 250 000.

Magnus Tobiasson, Hematology Unit/HERM.
Title: Exploring Stem and Immune Cell Dynamics Post- Relapse in Myelodysplastic Syndrome Patients Following Allogeneic Stem Cell Transplantation.
Amount granted for 2025-2027: SEK 3 000 000.

Eckardt Treuter, Biosciences and Nutrition Unit.
Titel: Role of epigenetic monocyte alterations in linking inflammatory type 2 diabetes and cancer via tumor-associated macrophages
Amount granted for 2025-2027: SEK 3 750 000.

Arnika Wagner, Hematology Unit/HERM.
Title: Identification and Elucidation of druggable targets to increase NK cells functions against Cancer.
Amount granted for 2025-2027: SEK 3 000 000.